Infering cellular mechanisms of tumor development from tissue-scale data: A Markov chain approach

Cancer as a disease causes about 8.8 million deaths worldwide per year, a number that will largely increase in the next decades. Although the cellular processes involved in tumor emergence are more and more understood, the implications of specific changes at the cellular scale on tumor emergence at the tissue scale remain elusive. Main reasons for this lack of understanding are that the cellular processes are often hardly observable especially in the early phase of tumor development and that the interplay between cellular and tissue scale is difficult to deduce. Cell-based mathematical models provide a valuable tool to investigate in which way observable phenomena on the tissue scale develop by cellular processes. The implications of these models can elucidate underlying mechanisms and generate quantitative predictions that can be experimentally validated. In this thesis, we infer the role of genetic and phenotypic cell changes on tumor development with the help of cell-based Markov chain models which are calibrated by tissue-scale data. In the first part, we utilize data on the diagnosed fractions of benign and malignant tumor subtypes to unravel the consequences of genetic cell changes on tumor development. We introduce extensions of Moran models to investigate two specific biological questions. First,

FIS:VIVO